Moreover, in metastatic melanoma, through immune exclusion, caused by deficient recruitment of dendritic cells (DC CD1031), the activation of the Wnt signaling pathway leads to the immunotherapy resistance of cancer cells against anti-PD-L1 and anti-CTLA-4 ΜοAbs [91,92]. This evidence concerns the gene CD274 and cancer.